Synthesis and Characterization of Two Impurities in Esomeprazole, an Antiulcerative Drug

被引：0

作者：

Liu, Xiao-ping ^{[1
,2
]}

Xu, Hui-lan ^{[1
]}

Sun, Rui ^{[2
]}

Li, Xue ^{[1
]}

Hu, Bao-hua ^{[2
]}

Hu, Chun ^{[1
,2
]}

机构：

[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China

[2] Yantai Valiant Fine Chem Co Ltd, Yantai 264006, Peoples R China

来源：

LATIN AMERICAN JOURNAL OF PHARMACY | 2015年 / 34卷 / 06期

基金：

美国国家科学基金会;

关键词：

characterization; esomeprazole; impurity; synthesis;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Impurity control is a key factor for drug quality. Study for impurities is helpful to optimize the production process and improve the quality of drugs. Synthesis and characterization of two of impurities in esomeprazole, which used for treatment of acid-related diseases was described in this paper. The two impurities are known as 2-[(3,5-dimethyl-4-methoxy-2-pyridinyl) methylsulfinyl]-1H-benzimidazole (impurity 1) and (R)-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl]-1H-benzimidazole (esomeprazole impurity F), whose structures are characterized with MS, IR, H-1-NMR and elemental analyses, and the purities of the two impurities are above 99% by HPLC analysis. The two target compounds can be used as the reference substance of the impurities of esomeprazole.

引用

页码：1265 / 1268

页数：4

共 50 条

[31] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
P. Rajesh Reddy
Sivanadh Musunuri
D. Rama Sekhara Reddy
V. Subrahmanyam Chittala
V. N. S. Murthy P
K. Krishnamohan
Future Journal of Pharmaceutical Sciences, 6
[32] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
Rajesh Reddy, P.
Musunuri, Sivanadh
Rama Sekhara Reddy, D.
Chittala, V. Subrahmanyam
Murthy, V. N. S. P.
Krishnamohan, K.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
[33] Synthesis and Characterization of Process-Related Impurities of Antihypertensive Drug Olmesartan Medoxomil
Venkanna, G.
Madhusudhan, G.
Mukkanti, K.
Sankar, A.
Kumar, Y. Sampath
Narayana, G. Venakata
JOURNAL OF CHEMISTRY, 2013, 2013
[34] Synthesis and characterization of irbesartan impurities
Satyanarayana, B.
Anjaneyulu, Y.
Veerasomaiah, P.
Reddy, P. Pratap
HETEROCYCLIC COMMUNICATIONS, 2007, 13 (04) : 223 - 228
[35] Separation and identification of degradation impurities of esomeprazole sodium
Xiao, Chuan
Yuan, Yingying
Li, Jianwang
Han, Yehua
Shi, Jiamin
Zeng, Wei
Zu, Xiaolong
Jin, Huijie
Jiang, Ru
Ni, Shouhai
BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (05)
[36] Synthesis and Characterization of Two Impurities in (S)-Pantoprazole as a Chiral Proton Pump Inhibitor
Ke, Jia
Deng, Xin-Shan
Li, Jin-Long
Li, Yong-Peng
Niu, Yuan-Yuan
Wang, Shao-Li
Liu, Xiao-Ping
Hu, Chun
LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (08): : 1668 - 1671
[37] Synthesis and Characterization of Metabolites and Potential Impurities of Balsalazide Disodium, an Anti-Inflammatory Drug
Khan, Md Umar
Baseer, M. A.
Kumar, S. Ranjith
Saravanakumar, M.
Prasannanjali, A. G.
Gupta, P. Badarinadh
Kaushik, Vipin K.
Handa, Vijay K.
Islam, Aminul
SYNTHETIC COMMUNICATIONS, 2010, 40 (15) : 2241 - 2253
[38] Synthesis and characterization of potential impurities of ezetimibe
Satheesh, Deekonda
Devi, Dharmasoth Rama
Basavaiah, Keloth
Sreenivasulu, B.
Reddy, Bhavanam Sekhara
Aegurla, Balakrishna
Kumar, Pallerla Satish
Guduri, Anil Kumar
Chavakula, Ramadas
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 60 (02) : 318 - 326
[39] Evaluation, synthesis and characterization of tacrolimus impurities
Ferraboschi, Patrizia
Colombo, Diego
De Mieri, Maria
Grisenti, Paride
JOURNAL OF ANTIBIOTICS, 2012, 65 (07): : 349 - 354
[40] Evaluation, synthesis and characterization of tacrolimus impurities
Patrizia Ferraboschi
Diego Colombo
Maria De Mieri
Paride Grisenti
The Journal of Antibiotics, 2012, 65 : 349 - 354

← 1 2 3 4 5 →